TOP TIERMARKET NEWSWIRE
News & sentiment

MANNKIND CORP (MNKD) — News & AI sentiment

MANNKIND CORP (MNKD) news roundup. 7 stories in the past week, 11 over 30 days. Average 30-day sentiment is 54/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $469K — net selling of $469K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
7
avg sentiment 57.9/100
30d stories
11
avg sentiment 54/100
Insider net (90d)
$469K
0 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

MNKD news in the last 24 hours, 7 days, 30 days and 90 days

How much MNKD coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowMNKD storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days757.9/100MNKD headlines →
Last 30 days1154/100MNKD headlines →
Last 90 days5153.7/100MNKD headlines →

Latest stories on MNKD

MannKind management to meet with Cantor
The Fly50 · neutralgeneral
2d ago
Cantor Fitzgerald reiterates Overweight on MannKind stock at $8
Investing.com Analyst Ratings61 · neutralanalyst
2d ago
4d ago
4d ago
4d ago
4d ago
4d ago
Sep 2
MannKind to Present at Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Sep 2
Aug 21
MANNKIND CORP (MNKD) files 8-K
SEC 8-K50 · neutralgeneral
Aug 21
Aug 13
Aug 6
H.C. Wainwright reiterates Buy rating on MannKind stock at $10
Investing.com Analyst Ratings61 · neutralanalyst
Aug 6
Aug 6
Aug 6
MANNKIND CORP (MNKD) files 8-K
SEC 8-K50 · neutralgeneral
Aug 5
Aug 5
Jul 31
Jul 30
MannKind stock reiterated at Buy by H.C. Wainwright on trial data
Investing.com Analyst Ratings61 · neutralanalyst
Jul 30
Jul 29
Jul 28
Jul 27
H.C. Wainwright reiterates MannKind stock rating on FDA approval
Investing.com Analyst Ratings65 · bullishanalyst
Jul 27
Open MNKD in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →